Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Ani Pharmaceuticals (ANIP) Long-Term Debt Issuances (2024)

Ani Pharmaceuticals (ANIP) has disclosed Long-Term Debt Issuances for 1 consecutive years, with $8.8 million as the latest value for Q4 2024.

  • Quarterly Long-Term Debt Issuances changed N/A to $8.8 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $8.8 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $325.0 million for FY2024, N/A changed from the prior year.
  • Long-Term Debt Issuances hit $8.8 million in Q4 2024 for Ani Pharmaceuticals.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $8.8 million in Q4 2024 to a low of $8.8 million in Q4 2024.